Tourette syndrome: evolving concepts.
paper
Cited
Public
Unavailable
- Authors
- Jankovic, Joseph; Kurlan, Roger
- Year
- 2011
- Journal
- Movement disorders : official journal of the Movement Disorder Society
- PMID
- 21484868
- DOI
- 10.1002/mds.23618
Tourette syndrome is a common childhood-onset neurobehavioral disorder characterized by multiple motor and phonic tics affecting boys more frequently than girls. Premonitory sensory urges prior to tic execution are common, and this phenomenon helps to distinguish tics from other hyperkinetic movement disorders. Tourette syndrome is commonly associated with attention deficit hyperactivity disorder, obsessive-compulsive disorder, learning difficulties, and impulse control disorder. The pathophysiology of this complex disorder is not well understood. Involvement of basal ganglia-related circuits and dopaminergic system has been suggested by various imaging and postmortem studies. Although it is considered a genetic disorder, possibly modified by environmental factors, an intense search has thus far failed to find causative genes. Symptomatic treatment of tics chiefly utilizes various alpha adrenergic agonists, antidopaminergic drugs, topiramate, botulinum toxin, and deep brain stimulation. Habit reversal therapy and other behavioral approaches may be a reasonable option for some cases. Improved understanding of Tourette syndrome should lead to better symptomatic and more effective pathogenesis-targeted therapies.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of Tourette's syndrome. | 2013 | 22889924 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A narrative review of Phase III and IV clinical trials for the pharmacological treatment of Tourette's syndrome in children, adults, and older adults. | Alharthi MS | β | 2025 | β |
| Efficacy and Safety of Acupuncture for Tourette Syndrome in Children: A Meta-Analysis and Systematic Review. | Lai S et al. | β | 2025 | β |
| Epidemiology of Tourette Syndrome. | Yilmaz AY et al. | β | 2025 | β |
| Exploring acupuncture as a therapeutic approach for tic disorders: a review of current understanding and potential benefits. | Liu H et al. | β | 2025 | β |
| Simple and Complex Phonic Tics in Tourette Syndrome. | Baizabal-Carvallo JF et al. | β | 2025 | β |
| Child Neurology: Simple Motor Tics Associated With Thalamic Ganglioglioma. | Chen Y et al. | β | 2024 | β |
| Closed-loop neurostimulation for the treatment of psychiatric disorders. | Sellers KK et al. | β | 2024 | β |
| Comparison of children and adults in deep brain stimulation for Tourette Syndrome: a large-scale multicenter study of 102 cases with long-term follow-up. | Gao Y et al. | β | 2024 | β |
| Diagnostic Criteria for Primary Tic Disorders: Time for Reappraisal. | Sarchioto M et al. | β | 2024 | β |
| Neuroimaging assessment of basal ganglia volumes in Tourette Syndrome: a systematic review and meta-analysis. | ErtΓΌrk H et al. | β | 2024 | β |
| Alternative patterns of deep brain stimulation in neurologic and neuropsychiatric disorders. | Najera RA et al. | β | 2023 | β |
| An Update on the Diagnosis and Management of Tic Disorders. | Desai I et al. | β | 2023 | β |
| Art as relaxation for tic disorders: a pilot randomised control study. | Choi H et al. | β | 2023 | β |
| Influence of Tiapride and Topiramate on Tic Severity and Behavioral/Emotional Problems in Children with Tourette Syndrome: A Retrospective Study. | Zhou X et al. | β | 2023 | β |
| Pediatric neuropsychiatric disorders with motor and nonmotor phenomena. | Younger DS | β | 2023 | β |
| Classifying major mental disorders genetically. | Cao H et al. | β | 2022 | β |
| Fecal transplantation can alleviate tic severity in a Tourette syndrome mouse model by modulating intestinal flora and promoting serotonin secretion. | Li H et al. | β | 2022 | β |
| Intellectual disability as a comorbidity in Tourette syndrome: a case report. | Sarongku T et al. | β | 2022 | β |
| Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study. | Schrag AE et al. | β | 2022 | β |
| Sex differences in patients with Tourette syndrome. | Baizabal-Carvallo JF et al. | β | 2022 | β |
| A Comprehensive Review of Tic Disorders in Children. | Ueda K et al. | β | 2021 | β |
| Association Between Tic Aggravation and Methylphenidate in Youth With Attention-Deficit/Hyperactivity Disorder. | Cha JY et al. | β | 2021 | β |
| Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome. | Billnitzer A et al. | β | 2021 | β |
| Recent progress on Tourette syndrome. | Ueda K et al. | β | 2021 | β |
| Revisiting the structure of the Yale Global Tic Severity Scale (YGTSS) in a sample of Chinese children with tic disorders. | Wen F et al. | β | 2021 | β |
| Tics induced by antiepileptic drugs: a pragmatic review. | Peters J et al. | β | 2021 | β |
| Tics, tremors and other movement disorders in childhood. | Blackburn J et al. | β | 2021 | β |
| Traditional Chinese Medicine Strategy for Patients with Tourette Syndrome Based on Clinical Efficacy and Safety: A Meta-Analysis of 47 Randomized Controlled Trials. | Wang N et al. | β | 2021 | β |
| Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in China. | Liu ZS et al. | β | 2020 | β |
| Modulation of Fibers to Motor Cortex during Thalamic DBS in Tourette Patients Correlates with Tic Reduction. | Andrade P et al. | β | 2020 | β |
| Mutations in ASH1L confer susceptibility to Tourette syndrome. | Liu S et al. | β | 2020 | β |
| Treatment options for tic disorders. | Rizzo R et al. | β | 2020 | β |
| Differentiating tics from functional (psychogenic) movements with electrophysiological tools. | Vial F et al. | β | 2019 | β |
| Habit Reversal Therapy in Obsessive Compulsive Related Disorders: A Systematic Review of the Evidence and CONSORT Evaluation of Randomized Controlled Trials. | Lee MT et al. | β | 2019 | β |
| Loss of Sight Caused by Ocular Self-Mutilative Behaviour: A Case of Malignant Tourette Syndrome. | AkgΓΌl Δ°F et al. | β | 2019 | β |
| Anteromedial GPi deep brain stimulation in Tourette syndrome: The first case series from Iran. | Azimi A et al. | β | 2018 | β |
| Critical aspects in the legal defence of patients with Tourette's Syndrome: An Italian case series. | Porta M et al. | β | 2018 | β |
| Ethics of Deep Brain Stimulation in Adolescent Patients with Refractory Tourette Syndrome: a Systematic Review and Two Case Discussions. | Smeets AYJM et al. | β | 2018 | β |
| Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders. | Pinares-Garcia P et al. | β | 2018 | β |
| Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. | Mouhamed Y et al. | β | 2018 | β |
| A marked point process approach for identifying neural correlates of tics in Tourette Syndrome. | Loza CA et al. | β | 2017 | β |
| Biomarkers and Stimulation Algorithms for Adaptive Brain Stimulation. | Hoang KB et al. | β | 2017 | β |
| Functional movement disorders. | Barbey A et al. | β | 2017 | β |
| Gilles de la Tourette syndrome. | Robertson MM et al. | β | 2017 | β |
| Lack of association between SLC5A7 polymorphisms and Tourette syndrome in a Chinese Han population. | Liu W et al. | β | 2017 | β |
| Systematic review of severity scales and screening instruments for tics: Critique and recommendations. | Martino D et al. | β | 2017 | β |
| Clinical Neurophysiological Evaluation for Simple Motor Tics. | Panyakaew P et al. | β | 2016 | β |
| Deep Brain Stimulation of the internal globus pallidus in refractory Tourette Syndrome. | Smeets AYJM et al. | β | 2016 | β |
| Handwriting Tics in Tourette's Syndrome: A Single Center Study. | Zanaboni Dina C et al. | β | 2016 | β |
| History of Botulinum Toxin Treatment in Movement Disorders. | Jabbari B | β | 2016 | β |
| In Reply: Evaluating Risks and Benefit of Deep Brain Stimulation for Treatment-Refractory Tourette Syndrome. | Servello D et al. | β | 2016 | β |
| Intermittent head drops: the differential spectrum. | Antelmi E et al. | β | 2016 | β |
| Thalamocortical network activity enables chronic tic detection in humans with Tourette syndrome. | Shute JB et al. | β | 2016 | β |
| Why so many deep brain stimulation targets in Tourette's syndrome? Toward a broadening of the definition of the syndrome. | Porta M et al. | β | 2016 | β |
| Advances in Tourette syndrome: diagnoses and treatment. | Serajee FJ et al. | β | 2015 | β |
| A positive diagnosis of functional (psychogenic) tics. | Demartini B et al. | β | 2015 | β |
| Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients. | Ji W et al. | β | 2015 | β |
| Chasing tics in the human brain: development of open, scheduled and closed loop responsive approaches to deep brain stimulation for tourette syndrome. | Almeida L et al. | β | 2015 | β |
| Did Mozart suffer from Asperger syndrome? | Raja M | β | 2015 | β |
| Myorhythmia: phenomenology, etiology, and treatment. | Baizabal-Carvallo JF et al. | β | 2015 | β |
| Novel targets and stimulation paradigms for deep brain stimulation. | De Jesus S et al. | β | 2015 | β |
| Psychogenic movement disorders. | Thenganatt MA et al. | β | 2015 | β |
| Recognizing uncommon presentations of psychogenic (functional) movement disorders. | Baizabal-Carvallo JF et al. | β | 2015 | β |
| The lived experiences of individuals with Tourette syndrome or tic disorders: a meta-synthesis of qualitative studies. | Smith H et al. | β | 2015 | β |
| The neuropsychiatric spectrum of motivational disorders. | Epstein J et al. | β | 2015 | β |
| Tics and tourette syndrome. | Ganos C et al. | β | 2015 | β |
| Tourette syndrome and procedures related to dental treatment: a systematic review. | Hansen JK et al. | β | 2015 | β |
| Deep brain stimulation and ablation for obsessive compulsive disorder: evolution of contemporary indications, targets and techniques. | Tierney TS et al. | β | 2014 | β |
| Environmental circumstances influencing tic expression in children. | CaurΓn B et al. | β | 2014 | β |
| [From tic disorders to Tourette syndrome: current data, comorbidities, and therapeutic approach in children]. | Fourneret P et al. | β | 2014 | β |
| Herbal medicines for treating tic disorders: a systematic review of randomised controlled trials. | Kim YH et al. | β | 2014 | β |
| Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. | Baldan LC et al. | β | 2014 | β |
| Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. | Wijemanne S et al. | β | 2014 | β |
| Progress in research on Tourette syndrome. | Black KJ et al. | β | 2014 | β |
| Sensory aspects of movement disorders. | Patel N et al. | β | 2014 | β |
| Sex differences in Parkinson's disease and other movement disorders. | Smith KM et al. | β | 2014 | β |
| The clinical features of psychogenic movement disorders resembling tics. | Baizabal-Carvallo JF et al. | β | 2014 | β |
| Tourette and tic disorders in ICD-11: standing at the diagnostic crossroads. | Woods DW et al. | β | 2014 | β |
| Treatment of Tourette syndrome. | Kurlan RM | β | 2014 | β |
| Autism spectrum disorders: the quest for genetic syndromes. | Zafeiriou DI et al. | β | 2013 | β |
| Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome. | Rizzo R et al. | β | 2013 | β |
| Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome. | Neri V et al. | β | 2013 | β |
| Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder. | Moya PR et al. | β | 2013 | β |
| Genome-wide association study of Tourette's syndrome. | Scharf JM et al. | β | 2013 | β |
| Immune-mediated animal models of Tourette syndrome. | Hornig M et al. | β | 2013 | β |
| Impaired inhibition of prepotent motor actions in patients with Tourette syndrome. | Wylie SA et al. | β | 2013 | β |
| Importance and hurdles to drug discovery for neurological disease. | Berger JR et al. | β | 2013 | β |
| Pharmacological treatment of Gilles de la Tourette syndrome. | Hartmann A et al. | β | 2013 | β |
| Sensory phenomena: clinical correlates and impact on quality of life in adult patients with Tourette syndrome. | Crossley E et al. | β | 2013 | β |
| Successful pallidal deep brain stimulation in 15-year-old with Tourette syndrome: 2-year follow-up. | Massano J et al. | β | 2013 | β |
| The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5Ξ±-reductase? | Bortolato M et al. | β | 2013 | β |
| The psychopathological spectrum of Gilles de la Tourette syndrome. | Cavanna AE et al. | β | 2013 | β |
| The use of deep brain stimulation in Tourette's syndrome. | Rotsides J et al. | β | 2013 | β |
| Deep brain stimulation for Tourette syndrome: target selection. | Viswanathan A et al. | β | 2012 | β |
| Deep brain stimulation for treatment of refractory Tourette syndrome: long-term follow-up. | Porta M et al. | β | 2012 | β |
| From ipse dixit to evidence-based guidelines: on the optimal management of Tourette syndrome. | Cavanna AE et al. | β | 2012 | β |
| Gene expression changes in peripheral blood from Chinese Han patients with Tourette syndrome. | Lei J et al. | β | 2012 | β |
| Habit reversal training for children with tourette syndrome: update and review. | Hwang GC et al. | β | 2012 | β |
| Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome. | Maling N et al. | β | 2012 | β |
| Movement disorders in autoimmune diseases. | Baizabal-Carvallo JF et al. | β | 2012 | β |
| Pediatric movement disorders: Five new things. | Blackburn JS et al. | β | 2012 | β |
| Perspectives on asymmetry: the Erickson Lecture. | Cohen MM | β | 2012 | β |
| Raclopride or high-frequency stimulation of the subthalamic nucleus stops cocaine-induced motor stereotypy and restores related alterations in prefrontal basal ganglia circuits. | Aliane V et al. | β | 2012 | β |
| The genetics of Tourette syndrome. | Deng H et al. | β | 2012 | β |
| The most cited works in Tourette syndrome. | Mariam N et al. | β | 2012 | β |
| Towards a better definition of the motor phenotype of Tourette syndrome. | Cardoso F | β | 2012 | β |
| Update on the role of antipsychotics in the treatment of Tourette syndrome. | Huys D et al. | β | 2012 | β |
| An introduction to dyskinesia--the clinical spectrum. | Ha AD et al. | β | 2011 | β |
| Sensory sensitivity to external stimuli in Tourette syndrome patients. | Belluscio BA et al. | β | 2011 | β |
| Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. | Jankovic J et al. | β | 2011 | β |
| Treatment of tics in patients with Tourette syndrome: recommendations according to the European Society for the Study of Tourette Syndrome. | MΓΌller-Vahl KR et al. | β | 2011 | β |